Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease

      Clinical Trials
      Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute (AWRI) at Nationwide...

      New Advanced DualBeam Increases Productivity and Expands Ease-of-Use

      Manufacturing
      Thermo Fisher Scientific unveiled its most advanced focused ion beam scanning electron microscope (FIB-SEM) for materials science researchers and engineers, the Thermo Scientific Helios...

      Lonza Partners with Vineti Across its Cell and Gene Therapy Manufacturing Network to Optimize Vein to Vein Delivery Service

      Manufacturing
      Lonza and Vineti announced their partnership in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network. As a part of this...

      Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab

      Manufacturing
      Omeros Corporation  and Lonza announced a long-term manufacturing agreement for commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2...

      China: Rising to the Active & Intelligent Packaging Challenge

      News
      The clear message from the highly successful AIPIA China Summit in Shanghai this July is that the country is ready to embrace the new...

      CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients

      Manufacturing
      CURE Pharmaceutical, an innovative drug delivery and development company, announced the allowance of U.S. Application No. 15/666,057, which covers edible thin films with natural...

      Boehringer Ingelheim Expands IPF Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

      News
      Boehringer Ingelheim and Bridge Biotherapeutics Inc. announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.